Literature DB >> 3015457

Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia.

G Fiorini, P Bernasconi, R A Sinico, R Chianese, F Pozzi, G D'Amico.   

Abstract

Antibodies to ubiquitous Herpes viruses have been studied in 13 patients with type II essential mixed cryoglobulinemia (EMC), and in two different control groups. All the EMC patients had monoclonal IgM kappa in their cryoprecipitates. IgM antibodies to the viral capsid antigen (VCA) of Epstein-Barr virus (EBV) were found in the sera of 11 EMC patients but all the cryoprecipitates were negative. IgG antibodies were also present in the sera of all and in the cryoprecipitates of some patients. In contrast, the number of subjects with antibodies to Cytomegalovirus (CMV) and Hepatitis B Virus (HBV) was not higher than in controls. Possible correlations between EMC and EBV infection are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015457      PMCID: PMC1542158     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  T cell defect in essential mixed cryoglobulinaemia.

Authors:  P L Meroni; G F Ciboddo; G Colombo; P Bonara; F Invernizzi
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

3.  Defective suppressor cell activity in essential mixed cryoglobulinemia.

Authors:  P L Meroni; W Barcellini; C Messina; G De Bartolo; F Capsoni; F Invernizzi
Journal:  J Clin Lab Immunol       Date:  1982-09

4.  Epstein-Barr virus-specific serology in immunologically compromised individuals.

Authors:  W Henle; G Henle
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M A Alspaugh; G Henle; E T Lennette; W Henle
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection.

Authors:  J W Popp; J L Dienstag; J R Wands; K J Bloch
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

8.  Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon.

Authors:  S H Cheeseman; W Henle; R H Rubin; N E Tolkoff-Rubin; B Cosimi; K Cantell; S Winkle; J T Herrin; P H Black; P S Russell; M S Hirsch
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

9.  Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.

Authors:  D T Purtilo; K Sakamoto; A K Saemundsen; J L Sullivan; A C Synnerholm; M Anvret; J Pritchard; C Sloper; C Sieff; J Pincott; L Pachman; K Rich; F Cruzi; J A Cornet; R Collins; N Barnes; J Knight; B Sandstedt; G Klein
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.

Authors:  D Geltner; E C Franklin; B Frangione
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

View more
  8 in total

Review 1.  Reappraisal of the clinical expression of mixed cryoglobulinemia.

Authors:  G Montagnino
Journal:  Springer Semin Immunopathol       Date:  1988

Review 2.  The kidney in mixed cryoglobulinemias.

Authors:  D J Cordonnier; J C Renversez; P Vialtel; E Dechelette
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Large quantities of low molecular weight IgM in mixed cryoglobulinaemia.

Authors:  P J Roberts-Thomson; A Kennedy; L Y Koh
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

4.  Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia.

Authors:  A Gabrielli; A Manzin; M Candela; M L Caniglia; S Paolucci; M G Danieli; M Clementi
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.

Authors:  P Cacoub; N Boukli; P Hausfater; A Garbarg-Chenon; P Ghillani; V Thibault; L Musset; J M Huraux; J C Piette
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

6.  Plasma fibronectin and microvascular damage in essential mixed cryoglobulinaemia.

Authors:  V Toschi; P Renoldi; A Motta; C Cimminiello; G Arpaia; G F Fiorini
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  In vitro synthesis of IgM rheumatoid factor by lymphocytes from patients with essential mixed cryoglobulinemia.

Authors:  P L Meroni; W Barcellini; R A Sinico; A Fornasieri; C Sguotti; F Invernizzi; G D'Amico; C Zanussi
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

Review 8.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.